You are here
Approvable Letter Issued for Timolol Combination Treatment
"The FDA's response necessitates additional clinical investigation," explained Dr. Scott Whitcup, Allergan's Executive Vice President, Research and Development. "Allergan has already initiated an additional clinical study that we currently anticipate will be completed by the end of 2004."
Source: Allergan, Inc.